Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2011 Mar;127(3):654–660. doi: 10.1016/j.jaci.2010.12.1111

Table 2. Safety profile – Number of subjects requiring treatment with epinephrine.

Active Placebo
Initial escalation day 2/19 0/9
Build-up visits 0 0
Home dosing 0 1
OFC 0/16 3/9

OFC = oral food challenge